Some patients successfully maintain with lower doses, spacing injections, or transitioning off medication after 2-3 years if they've built sustainable habits and addressed underlying metabolic dysfunction
Rapamycin's interest in longevity protocols involves its action on the mTOR pathway , which researchers have studied in the context of aging processes in animal models and, more recently, in human contexts
But its not without risks
If so, we can provide the following peptide options: AOD-9604 Aids in weight loss
In the study, participants with a responsive genetic score had an 82% increase in the likelihood of acheiving weight loss with a GLP-1 medication.[ref] Another study showed that GLP1 receptor variants are associated with greater weight loss on GLP-1 RA drugs.[ref] Common genetic variants in the GLP1R (GLP-1 receptor) gene impact weight and type 2 diabetes risk
The mention of mTOR pathways reveals another crucial layer the cellular control systems that decide when and how rapidly tissue growth occurs